Anti-mullerian hormone in young women after chemotherapy and infradiaphragmatic radiotherapy for childhood cancer
Journal Title: Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego - Year 2008, Vol 14, Issue 2
Abstract
Introduction: Composed anticancer treatment leads to different late effects, such as ovarian failure, causing infertility or premature menopause. Aim of the study was to analyse ovarian function, particularly anti-mullerian hormone levels, in young females after anticancer treatment. Patients and methods: We analysed FSH, LH, estradiol and anti-mullerian hormone (AMH) levels on days 3-5 of a menstrual cycle in thirty three cancer survivors in mean age 19.1±4.7 years treated in age 12.0±5.6 years for Hodgkin Lymphoma (HL) (n=16), nephroblastoma (n=7), soft tissue sarcoma (n=4), germinal tumor (n=3), neuroblastoma (n=2), histiocytosis (n=1). Infradiaphragmatic radiotherapy was needed in 16 patients (10 treated for HL). Results were compared with healthy girls of the same age. Results: The mean values of FSH, LH, E2 and AMH did not differ in all survivors comparing to controls. Patients treated for HL with chemo- and radiotherapy presented higher FSH levels than controls (8.53±3.25 vs. 5.8±2.03 mIU/ml; p=0.045). Mean AMH levels were lower in all patients that received radiotherapy for the infradiaphragmatic region (17.19±14.84 pmol/l) than in controls (29.40±13.2 pmol/l; p=0.037). Particular analysis of all cases showed higher (>2 SD) FSH levels in 8 patients: 5 patients treated for HL with radiotherapy and higher total doses of procarbazine, nitrogen mustard and vinblastine; 2 patients treated for soft tissue sarcoma and one patient for Wilms tumor (all received radiotherapy). Lowered AMH levels were found in 8 patients treated with chemo- and radiotherapy (4 – for HL, 2 – for Wilms tumor and 2 – for soft tissue sarcoma). Conclusion: Composed anticancer treatment, especially radiotherapy, leads to ovarian failure. Decreased AMH values at young adulthood suggest a lower ovarian reserve. All causes and first symptoms of ovary damage should be known to the doctors who take care of the patients after anticancer treatment.
Authors and Affiliations
Maryna Krawczuk-Rybak, Elżbieta Leszczyńska, Jolanta Wysocka, Beata Żelazowska-Rutkowska
Keywords
Related Articles
- EP ID EP84185
- DOI -
- Views 109
- Downloads 0
Interrelationship between endothelial dysfunction, IMT of the carotid arteries and adhesion molecules in obese hypertensive children and adolescents
Introduction: Adhesion molecules released by dysfunctional endothelial cells are markers of an early atherosclerotic process. Ultrasonography of the brachial arteries (flow mediated dilatation – FMD) is used to detect an...
Rozumienie zdrowia przez młodziez chorujaca na cukrzyce typu 1 w oparciu o własne kryteria.
The influence of polymorphism the Gly972Arg variant insulin receptor substrate-1 (IRS-1) gene, and G-308A TNF-a gene on obesity and insulin resistance in children with obesity
Genetic factors play a role in the pathogenesis of insulin resistance in obese subjects. The insulin receptor substrate-1 (IRS-1) and IRS-2 are the most important elements of the insulin-signaling pathways, and mutations...
Cardiovascular system disease in youth patients with various forms of glucose metabolism impairment – diagnosis and treatment
For many years chronic complications of diabetes in adolescent patients were linked mainly to microangiopathy. New, more and more accurate, diagnostic methods, making noninvasive diagnosis of very early lesions in the va...
Genetic syndrome, most likely vascular type of Ehlers-Danlos syndrome, in a 14-years old boy with extrapyramindal symptoms dominating the early childhood and growth failure
Introduction: The Ehlers-Danlos Syndrome (EDS) is a heterogeneous group of rare genetic disorders with various clinical features, which result from faulty collagen structure or disturbances in collagen synthesis. The ca...